Gross profit for various pharmaceutical distributors before EBITDA from 2016-2017

This statistic shows the share of gross profit converted to earnings before interest, taxes, depreciation and amortization among various levels of U.S. pharmaceutical supply chains in 2016-2017. According to the data, pharmacy benefit managers converted 85 percent of gross profits to EBITDA.

Share of gross profit converted to EBITDA among U.S. drug supply chain levels in 2016-2017*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

July 2019

Region

United States

Survey time period

2016 and 2017

Supplementary notes

Calculated as EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) margin divided by gross margin

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.